Skip to search formSkip to main contentSkip to account menu

Proplex

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Prothrombin complex concentrates (PCC) have been used as bypassing agents for the treatment of haemophilia A patients with… 
2007
2007
Regular self‐infusion of an activated prothrombin complex concentrate (APCC) has been successfully introduced to a 14‐year‐old… 
1992
1992
We established a method for measuring procoagulant action on human umbilical vein endothelial cells (HUVEC). HUVEC (2.5 x 10(4… 
1984
1984
  • C. Kasper
  • 1984
  • Corpus ID: 20858975
The management of hemorrhages in patients with strong inhibitors to factor VIII continues to challenge our ingenuity. No therapy… 
1977
1977
There has been no systematic re-examination of variables that may affect the level and duration of response of patients with… 
1977
1977
HBsAg was detected in two commercial clotting factor concentrates: Proplex (Hyland) and Konyne (Cutter). HBsAg was positive by… 
1977
1977
Proplex (P), Konyne, and Auto-Factor IX (A) are PCC which can promote hemostasis in patients with hemophilia A with circulating… 
1977
1977
  • J. PennerP. Kelly
  • 1977
  • Corpus ID: 21181503
To the Editor.— Our most recent experience with the prothrombin concentrate Konyne in factor VIII inhibitor patients has shown… 
1973
1973
A comparative clinical study was performed of two commercial preparations of prothrombin complex concentrates, Proplex and Konyne…